Suchergebnisse - "Heil, Emily L"

PubPharm (8)

1

In a Pinch : Cefiderocol for CRAB Infections

enthalten in: Antimicrobial agents and chemotherapy | 2022

von Karaba, S. | Hirsch, E. | Heil, E.

CommentOn: Antimicrob Agents Chemother. 2022 May 17;66(5):e0214221. - PMID 35311522

2

The role of tazobactam-based combinations for the management of infections due to extended-spectrum β-lactamase-producing Enterobacterales : Insights from the Society of Infectious Diseases Pharmacists

enthalten in: Pharmacotherapy | 2021

von Monogue, M. | Heil, E. | Aitken, S. | +1

3

New Perspectives on Antimicrobial Agents : Cefiderocol

enthalten in: Antimicrobial agents and chemotherapy | 2021

von McCreary, E. | Heil, E. | Tamma, P.

4

Cefiderocol : the Trojan horse has arrived but will Troy fall?

enthalten in: The Lancet. Infectious diseases | 2021

von Heil, E. | Tamma, P.

CommentOn: Lancet Infect Dis. 2021 Feb;21(2):226-240. - PMID 33058795

5

Impact of CLSI and EUCAST Cefepime breakpoint changes on the susceptibility reporting for Enterobacteriaceae

enthalten in: Diagnostic microbiology and infectious disease | 2017

von Bork, J. | Heil, E. | Leekha, S. | +4

6

Treatment options for extended-spectrum beta-lactamase (ESBL) and AmpC-producing bacteria

enthalten in: Expert opinion on pharmacotherapy | 2016

von D'Angelo, R. | Johnson, J. | Bork, J. | +1

7

Ceftolozane-Tazobactam Pharmacokinetics in a Critically Ill Patient on Continuous Venovenous Hemofiltration

enthalten in: Antimicrobial agents and chemotherapy | 2015

von Oliver, W. | Heil, E. | Gonzales, J. | +4

8

Treatment of multidrug-resistant pseudomonas aeruginosa using extended-infusion antimicrobial regimens

enthalten in: Pharmacotherapy | 2015

von Heil, E. | Lowery, A. | Thom, K. | +1

1
[1]